CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials

Journal of Clinical Oncology

Volumn 21, Issue 9, 2003, Pages 1798-1809

  Clarke, M ^a   Gaynon, P ^a   Hann, I ^a   Harrison, G ^a   Masera, G ^a   Peto, R ^a   Richards, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG MEGADOSE; HUMAN; INTERMETHOD COMPARISON; LOG RANK TEST; LONG TERM CARE; MEDICAL SOCIETY; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; ACUTE LYMPHOCYTIC LEUKEMIA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DISEASE FREE SURVIVAL; FEMALE; INFANT; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; INJECTIONS, SPINAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TREATMENT OUTCOME;

EID: 0038473997     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.047     Document Type: Article

References (77)

1. Aur RJA, Simone JV, Hustu HO, et al: A comparative study of CNS irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer 29:381-391, 1972
2. Ortega JA, Nesbit ME, Sather HN, et al: Long-term evaluation of a CNS prophylaxis trial: Treatment comparisons and outcome after CNS relapse in childhood ALL. A report from the Children's Cancer Study Group. J Clin Oncol 5:1646-1654, 1987
3. Ochs J, Mulhern R: Long-term sequelae of therapy for childhood acute lymphoblastic leukemia. Baillieres Clin Hematol 7:365-376, 1994
4. Clayton PE, Shalet SM, Morris-Jones PH, et al: Growth in children treated for acute lymphoblastic leukemia. Lancet 1:460-462, 1988
5. Wheeler K, Leiper AD, Jannoun L, et al: Medical cost of curing childhood acute lymphoblastic leukemia. Br Med J 296:162-166, 1988
6. Leiper AD: Management of growth failure in the treatment of malignant disease. Pediatr Hematol Oncol 7:365-371, 1990
7. Kimball Dalton VM, Gelber RD, Li F, et al: Second malignancies in patients treated for childhood acute lymphoblastic leukemia. J Clin Oncol 16:2848-2853, 1998
8. Walter AW, Hancock ML, Pui C-H, et al: Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 16:3761-3767, 1998
9. Green DM, Hyland A, Chung CS, et al: Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. J Clin Oncol 17:3207-3215, 1999
10. Löning L, Zimmermann M, Reiter A, et al: Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy. Blood 95:2770-2775, 2000
11. Hudson MM, Jones D, Boyett J, et al: Late mortality of long-term survivors of childhood cancer. J Clin Oncol 15:2205-2213, 1997
12. Cousens P, Waters B, Said J, et al: Cognitive effects of cranial irradiation in leukemia: A survey and meta-analysis. J Child Psychol Psychiatry 29:839-852, 1988
13. Bleyer WA, Fallavollita J, Robison L, et al: Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: A report from the Children's Cancer Study Group. Pediatr Hematol Oncol 7:329-338, 1990
14. Waber DP, Tarbell NJ, Kahn CM, et al: The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia. J Clin Oncol 10:810-817, 1992
15. Christie D, Leiper AD, Chessells JM, et al: Intellectual performance after presymptomatic cranial radiotherapy for leukemia: Effects of age and sex. Arch Dis Child 73:136-140, 1995
16. Jankovic M, Brouwers P, Valsecchi MG, et al: Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukemia: ISPACC, International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 344:224-227, 1994
17. Silber JH, Radcliffe J, Peckham V, et al: Whole brain irradiation and decline in intelligence: The influence of dose and age on IQ score. J Clin Oncol 10:1390-1396, 1992
18. Stewart LA, Parmar MK: Meta-analysis of the literature or of individual patient data: Is there a difference? Lancet 341:418-422, 1993
19. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1-15, 1992
20. Early Breast Cancer Trialists' Collaborative Group: Treatment of Early Breast Cancer, Vol 1: Worldwide Evidence 1985 to 1990. Oxford, Oxford University Press, 1990
21. van Eys J, Berry D, Crist W, et al: A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood: A Pediatric Oncology Group study. Cancer 63:23-29, 1989
22. Littman P, Coccia P, Bleyer WA, et al: CNS (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL). Int J Radiat Oncol Biol Phys 13:1443-1449, 1987
23. Ortega JJ, Javier G, Olive T: Treatment of standard- and high-risk childhood acute lymphoblastic leukemia with two CNS prophylaxis regimens. Haematol Blood Transfus 30:483-492, 1987
24. Tubergen DG, Gilchrist GS, O'Brien RT, et al: Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy. A Childrens Cancer Group report. J Clin Oncol 11:520-526, 1993
25. Stark B, Abramov A, Attias D, et al: Extended intrathecal triple therapy for preventing CNS relapse in non very high risk childhood acute lymphoblastic leukemia treated with the Israeli studies INS-84 and INS-89 (modified BFM-86). Proc Am Soc Clin Oncol 15:367, 1996 (abstr 1087)
26. Nachman J, Sather HN, Cherlow JM, et al: Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group. J Clin Oncol 16:920-930, 1998
27. Gaynon PS, Steinherz PG, Reaman GH, et al: Strategies for the treatment of children with acute lymphoblastic leukemia and unfavourable presenting features. Haematol Blood Transfus 30:167-172, 1987
28. Niemeyer CM, Reiter H, Donnelly M, et al: Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols. Ann Oncol 2:745-749, 1991
29. Lange BJ, Blatt J, Sather HN, et al: Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Children's Cancer Group study. Med Pediatr Oncol 27:15-20, 1996
30. LeClerc JM, Billett AL, Gelber RD, et al: Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol 20:237-246, 2002
31. Richards S, Burrett J, Hann I, et al: Improved survival with early intensification: Combined results from the Medical Research Council childhood ALL randomized trials, UKALL X and UKALL XI. Leukemia 12:1031-1036, 1998
32. Masson E, Relling MV, Synold TW, et al: Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest 97:73-80, 1996
33. Schaison GS, Baruchel A, Leblanc T, et al: Therapy of childhood acute lymphoblastic leukemia. Int J Pediatr Hematol Oncol 5:145-154, 1998
34. Freeman AI, Boyett JM, Glicksman AS, et al: Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up. Med Pediatr Oncol 28:98-107, 1997
35. Schrappe M, Reiter A, Henze G, et al: Prevention of CNS recurrence in childhood ALL: Results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials. Klin Pädiatr 210:192-199, 1998
36. Zintl F, Plenert W, Malke H: Results of acute lymphoblastic leukemia therapy in childhood with a modified BFM protocol in a multicenter study in the German Democratic Republic. Haematol Blood Transfus 30: 471-479, 1987
37. Chessells JM, Durrant J, Hardy RM, et al: Medical Research Council leukemia trial UKALL V: An attempt to reduce immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. J Clin Oncol 4:1758-1764, 1986
38. Eden OB, Lilleyman JS, Richards S: Testicular irradiation in childhood lymphoblastic leukemia. Br J Hematol 75:496-498, 1990
39. Lilleyman JS, Richards S, Rankin A: Medical Research Council leukemia trial, UKALL VII. Arch Dis Child 60:1050-1054, 1985
40. Brandalise S, Odone V, Pereira W, et al: Treatment results of three consecutive Brazilian cooperative childhood protocols: GBTLI-80, GBTLI-82 and -85. Leukemia 7:S142-S145, 1993 (suppl 2)
41. Tsukada M, Komiyama A, Nakazawa S, et al: Treatment of standard risk acute lymphoblastic leukemia in children with the Tokyo Children Cancer Study Group (TCCSG) L84-11 protocol in Japan. Int J Hematol 57:1-7, 1993
42. Tsurusawa M, Katano N, Yamamoto Y, et al: Improvement in CNS protective treatment in nonhigh-risk childhood acute lymphoblastic leukemia: Report from the Japanese Children's Cancer and Leukemia Study Group. Med Pediatr Oncol 32:259-266, 1999
43. Viana MB, Murao M, Ramos G, et al: Malnutrition as a prognostic factor in lymphoblastic leukemia: A multivariate analysis. Arch Dis Child 71:304-310, 1994
44. Zintl F, Malke H, Reimann M, et al: Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987. Haematol Blood Transfus 33:478-482, 1990
45. Aur RJA, Hustu HO, Verzosa MS, et al: Comparison of two methods of preventing CNS leukemia. Blood 42:349-357, 1973
46. Nesbit ME, Sather HN, Robison LL, et al: Presymptomatic CNS therapy in previously untreated childhood acute lymphoblastic leukemia: Comparison of 1,800 rad and 2,400 rad. A report for Children's Cancer Study Group. Lancet 1:461-466, 1981
47. Bleyer WA: Intrathecal methotrexate versus CNS leukemia. Cancer Drug Deliv 1:157-167, 1984
48. Vilmer E, Suciu S, Ferster A, et al: Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report. Leukemia 14:2257-2266, 2000
49. Wolfrom C, Hartmann R, Fengler R, et al: Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood leukemia. J Clin Oncol 11:827-833, 1993
50. Donadieu J, Auclerc M-F, Baruchel A, et al: Critical study of prognostic factors in childhood acute lymphoblastic leukemia: Differences in outcome are poorly explained by the most significant prognostic variables. Br J Haematol 102:729-739, 1998
51. Bührer C, Hartmann R, Fengler R, et al: Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. J Clin Oncol 14:2812-2817, 1996
52. Holland JF, Glidewell O: Chemotherapy of acute lymphocytic leukemia of childhood. Cancer 30:1480-1487, 1972
53. Duttera MJ, Bleyer WA, Pomeroy TC, et al: Irradiation, methotrexate toxicity, and the treatment of meningeal leukemia. Lancet 2:703-707, 1973
54. Sackmann-Muriel F, Pavlovsky S, Penalver JA, et al: Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia. Cancer 34:418-426, 1974
55. Jones B, Freeman AI, Shuster JJ, et al: Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol: 269-275, 1991
56. Henderson ES, Scharlau C, Cooper MR, et al: Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113. Leuk Res 3:395-407, 1979
57. Moss HA, Nannis ED, Poplack DG: The effects of prophylactic treatment of the cranial nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med 71:47-52, 1981
58. Komp DM, Fernandez CH, Falletta JM, et al: CNS prophylaxis in acute lymphoblastic leukemia. Cancer 50:1031-1036, 1982
59. Dritschilo A, Cassady JR, Camitta B, et al: The role of irradiation in CNS treatment and prophylaxis for acute lymphoblastic leukemia. Cancer 37:2729-2735, 1976
60. MRC Working Party on leukemia in childhood: Effects of varying radiation schedule, cyclophosphamide treatment, and duration of treatment in acute lymphoblastic leukemia. Br Med J 2:787-791, 1978
61. Brecher ML, Berger P, Freeman AI, et al: Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of CNS prophylaxis. Cancer 56:2430-2433, 1985
62. Land VJ, Thomas PRM, Boyett JM, et al: Comparison of maintenance treatment regimens for first CNS relapse in children with acute lymphocytic leukemia: A Pediatric Oncology Group study. Cancer 56:81-87, 1985
63. Poplack DG, Reaman GH, Bleyer WA, et al: CNS preventive therapy with high-dose methotrexate in acute lymphoblastic leukemia: a preliminary report. Proc Am Soc Clin Oncol 3:204, 1984 (abstr 797)
64. Pullen J, Boyett J, Shuster J, et al: Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 11:839-849, 1993
65. Tanimoto M, Miyawaki S, Ino T, et al: Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 study of the Japan Adult Leukemia Study Group (JALSG). Int J Hematol 68:421-429, 1998
66. Silverman LB, Gelber RD, Dalton VK, et al: Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01. Blood 97:1211-1218, 2001
67. Mahoney DH, Shuster JJ, Nitschke R, et al: Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy. A Pediatric Oncology Group study. J Clin Oncol 16:1712-1722, 1998
68. Mahoney DH, Shuster JJ, Nitschke R, et al: Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 18:1285-1294, 2000
69. Mahoney DH, Shuster JJ, Nitschke R, et al: Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group phase III trial. J Clin Oncol 16:246-254, 1998
70. Pui CH, Evans WE: Acute lymphoblastic leukemia. N Engl J Med 339:605-615, 1998
71. Anderson VA, Godber T, Smibert E, et al: Cognitive and academic outcome following cranial irradiation and chemotherapy in children: A longitudinal study. Br J Cancer 82:255-262, 2000
72. Van Dongen-Melman JEWM, De Groot A, Van Dongen JJM, et al: Cranial irradiation is the major cause of learning problems in children treated for leukemia and lymphoma: A comparative study. Leukemia 11:1197-1200, 1997
73. Eiser C, Hill JJ, Vance YH: Examining the psychological consequences of surviving childhood cancer: systematic review as a research method in pediatric psychology. J Pediatr Psychol 25:449-460, 2000
74. Childhood ALL Collaborative Group: Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukemia: Overview of 42 trials involving 12,000 randomized children. Lancet 347:1783-1788, 1996
75. Hill JM, Kornblith AB, Jones D, et al: A comparative study of the long-term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 82:208-218, 1998
76. Kaleita TA, Tubergen DG, Stehbens JA, et al: Longitudinal study of cognitive, motor, and behavioral functioning in children diagnosed with acute lymphoblastic leukemia: a report of early findings from the Childrens Cancer Group. Haematol Blood Transfus 38:660-673, 1997
77. Hill FGH, Vergha-Khadem F, Gibson B, et al: UKALL XI randomized trial stratified CNS treatments and prospective neuropsychological assessment in childhood acute lymphoblastic leukemia (ALL). Presented at 42nd Annual Meeting Am Soc Hematol, San Francisco, CA, December 1-5, 2000 (abstr 2006)